Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles
Authors:
- 28 July 2012
- journal article
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 17 (4) , 755-763
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiaeJournal of Biotechnology, 2010
- Biopharmaceutical benchmarks 2010Nature Biotechnology, 2010
- Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in IndiaNature Biotechnology, 2010
- Replication and Assembly of Human PapillomavirusesJournal of Dental Research, 2009
- A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody ResponseJournal of Virology, 2008
- Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particlesJournal of General Virology, 2007
- Downstream processing of viral vectors and vaccinesGene Therapy, 2005
- Towards the preparative and large-scale precision manufacture of virus-like particlesTrends in Biotechnology, 2005
- Stabilization of human papillomavirus virus-like particles by non-ionic surfactantsJournal of Pharmaceutical Sciences, 2005
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970